Dr. Jonathon Burman presents: Molecular mechanisms underlying the selectivity of PINK1/Parkin-mediated mitophagy

Published: July 28th, 2017

Category: Seminars

Date: August 17, 2017
Speaker(s): Jonathon Burman, Ph.D., NIH, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Location: CTRB, 2004 Mowry Rd, Room 2161

Please note that this seminar occurs on a Thursday, instead of our regular Monday seminar.

BurmanFlyer_web

Learning Objectives:  At the conclusion of this presentation, participants should be able to:

  1. Describe how the Parkinson’s disease-associated genes PINK1 and parkin function together to facilitate mitochondrial autophagy (mitophagy)
  2. Identify the role that mitochondrial fission has in determining the selectivity of mitophagy
  3. Assess the clinical significance that PINK1/Parkin-activating compounds may have in the treatment of mitochondrial-associated diseases.

Dr. Burman has disclosed no relevant financial relationships. No one else in a position to control content has any financial relationship(s) to disclose.

CME Information:

Accreditation:

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit:

The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The VA designates 1.0 hour of Continuing Education credit provided for its employees.

Series  #8115